Synmosa Biopharma Corporation 4114.TWO Stock
Synmosa Biopharma Corporation Price Chart
Synmosa Biopharma Corporation 4114.TWO Financial and Trading Overview
| Synmosa Biopharma Corporation stock price | 38.8 TWD |
| Previous Close | 44.65 TWD |
| Open | 44.25 TWD |
| Bid | 44.4 TWD x N/A |
| Ask | 44.5 TWD x N/A |
| Day's Range | 44.25 - 44.85 TWD |
| 52 Week Range | 25.51 - 55.8 TWD |
| Volume | 1.91M TWD |
| Avg. Volume | 6.3M TWD |
| Market Cap | 14.65B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 18.196722 |
| EPS (TTM) | 1.61 TWD |
| Forward Dividend & Yield | 0.5 (1.11%) |
| Ex-Dividend Date | July 11, 2022 |
| 1y Target Est | 50 TWD |
4114.TWO Valuation Measures
| Enterprise Value | 14.54B TWD |
| Trailing P/E | 18.196722 |
| Forward P/E | 19.055796 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.7129416 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Synmosa Biopharma Corporation Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 69.86% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 55.8 TWD |
| 52 Week Low | 25.51 TWD |
| 50-Day Moving Average | 45.93 TWD |
| 200-Day Moving Average | 42.39 TWD |
4114.TWO Share Statistics
| Avg. Volume (3 month) | 6.3M TWD |
| Avg. Daily Volume (10-Days) | 2.67M TWD |
| Shares Outstanding | 329.99M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 25.41% |
| % Held by Institutions | 4.04% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.2061 |
| Last Split Factor | 1101.3506:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 13.49 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 2.44 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 16.366 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Synmosa Biopharma Corporation
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 396, Neihu Road |
| ZIP | 114 |
| Phone | 886 2 8797 7100 |
| Website | https://www.synmosa.com.tw |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, hormones, and other forms. It also offers contract manufacturing services. In addition, it exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua. The company was incorporated in 1980 and is based in Taipei, Taiwan.
Q&A For Synmosa Biopharma Corporation Stock
What is a current 4114.TWO stock price?
Synmosa Biopharma Corporation 4114.TWO stock price today per share is 38.8 TWD.
How to purchase Synmosa Biopharma Corporation stock?
You can buy 4114.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Synmosa Biopharma Corporation?
The stock symbol or ticker of Synmosa Biopharma Corporation is 4114.TWO.
Which industry does the Synmosa Biopharma Corporation company belong to?
The Synmosa Biopharma Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does Synmosa Biopharma Corporation have in circulation?
The max supply of Synmosa Biopharma Corporation shares is 384.86M.
What is Synmosa Biopharma Corporation Price to Earnings Ratio (PE Ratio)?
Synmosa Biopharma Corporation PE Ratio is 24.09937900 now.
What was Synmosa Biopharma Corporation earnings per share over the trailing 12 months (TTM)?
Synmosa Biopharma Corporation EPS is 1.61 TWD over the trailing 12 months.
Which sector does the Synmosa Biopharma Corporation company belong to?
The Synmosa Biopharma Corporation sector is Healthcare.